- A. Health Biotechnology
- Areas of activity
- In vitro diagnostics
- Therapeutic areas
- Digestive system and hepatology
Venter Pharma SL is a biotech Company created in 2003 with the aim of developing products in the field of gastroenterology to help patients and professionals.
Venter Pharma SL was founded in 2003 under the name of Lactest SL, upon the development work carried out in the Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas (CSIC).
During these years, in deep collaboration with UAM and CSIC, the company has developed the method for the evaluation of lactose intolerance, completed the preclinical and clinical studies to determine the toxicity and efficacy of the product and finished the scaling up of the product.
Venter Pharma has developed LacTEST 0.45 podwer for oral solution, a diagnostic drug for the diagnosis of lactose intolerance that overcomes the deficiencies of current methods. LacTEST is based on a new molecule which INN is gaxilose
LacTEST finished the development process in 2009 and the European authorization process in 2011. Now the company is waiting for the approval of the Spanish and German health Agencies.